Insider · CIK 0001297259
Shai Gozani
ceopresidentofficerdirector
Files at NURO (NeuroMetrix, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | NURO NeuroMetrix, Inc. | DDisposition to issuer Common Stock | -15,466 | - | - | 0 | May 5, 2025 |
| May 1, 2025 | NURO NeuroMetrix, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -4,384 | - | - | 0 | May 5, 2025 |
| Apr 1, 2025 | NURO NeuroMetrix, Inc. | MOption exercise Common Stock | +625 | $4.41 | $2,756 | 15,544 | Apr 3, 2025 |
| Apr 1, 2025 | NURO NeuroMetrix, Inc. | FTax withholding Common Stock | -78 | $4.41 | $344 | 15,466 | Apr 3, 2025 |
| Apr 1, 2025 | NURO NeuroMetrix, Inc. | MOption exercise Restricted Stock Unitderivative | -625 | $4.41 | $2,756 | 3,750 | Apr 3, 2025 |
| Feb 2, 2025 | NURO NeuroMetrix, Inc. | MOption exercise Common Stock | +636 | $4.31 | $2,741 | 14,998 | Feb 5, 2025 |
| Jan 1, 2025 | NURO NeuroMetrix, Inc. | MOption exercise Common Stock | +625 | $3.97 | $2,481 | 14,437 | Feb 5, 2025 |
| Feb 2, 2025 | NURO NeuroMetrix, Inc. | FTax withholding Common Stock | -79 | $4.31 | $340 | 14,919 | Feb 5, 2025 |
| Jan 1, 2025 | NURO NeuroMetrix, Inc. | FTax withholding Common Stock | -75 | $3.97 | $298 | 14,362 | Feb 5, 2025 |
| Feb 2, 2025 | NURO NeuroMetrix, Inc. | MOption exercise Restricted Stock Unitderivative | -636 | $4.31 | $2,741 | 634 | Feb 5, 2025 |
| Jan 1, 2025 | NURO NeuroMetrix, Inc. | MOption exercise Restricted Stock Unitderivative | -625 | $3.97 | $2,481 | 4,375 | Feb 5, 2025 |
| Nov 2, 2024 | NURO NeuroMetrix, Inc. | MOption exercise Common Stock | +636 | $4.00 | $2,544 | 13,854 | Nov 5, 2024 |
| Nov 2, 2024 | NURO NeuroMetrix, Inc. | FTax withholding Common Stock | -42 | $4.00 | $168 | 13,812 | Nov 5, 2024 |
| Nov 2, 2024 | NURO NeuroMetrix, Inc. | MOption exercise Restricted Stock Unitderivative | -636 | $4.00 | $2,544 | 1,270 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.